✦ LIBER ✦

Hepatitis C and G co-infection: Response to interferon therapy and quantitative changes in serum HGV-RNA

✍ Scribed by J G McHutchison; O V Nainan; M J Alter; A Sedghi-Vaziri; J Detmer; M Collins; J Kolberg

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 323 KB
Volume: 26
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510260534

No coin nor oath required. For personal study only.

✦ Synopsis

Hepatitis G virus (HGV), a positive sense RNA virus, is distantly related to hepatitis C virus (HCV): its genetic organization and identity are consistent with the Flaviviridae family. Coinfection with HGV occurs in 10% to 20% of HCV-infected subjects. These similarities raise two theoretical questions. First, could HGV coinfection play any role in the response of HCV to antiviral therapy and second, would this coinfected population have changes in serum HGV-RNA induced by interferon. To address these questions, 98 patients with documented chronic HCV underwent interferon therapy (3 million units three times a week) for 6 months. Response to therapy was categorized using standard biochemical criteria. Changes in HGV-RNA levels were evaluated before, during, and after interferon therapy by a quantitative branched DNA amplification research-based assay. Eleven of 98 (11%) patients with HCV infection had detectable serum HGV-RNA. There was no difference between the groups (HGV+ vs. HGV-) when baseline alanine aminotransferase (ALT) values, HCV-RNA levels, HCV genotype, histological severity, or other demographic features were analyzed. Interferon response was similar in both groups and HGV was not associated with outcome following therapy. Antiviral therapy appeared to induce a reduction in HGV-RNA load in five of nine patients coinfected with HCV serially tested. In two patients, the fall in serum HGV-RNA correlated with biochemical response, independent of changes in HCV-RNA. These observations indicate that a larger study of an HGV population is required to more clearly define the relationship between HCV and HGV coinfection and their response to antiviral therapy.

📜 SIMILAR VOLUMES

Serum hepatitis C virus RNA level as a p

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C

✍ Etsuro Onto; Masashi Mizokami; Tatsunori Nakano; Hisahiro Terashima; Osamu Nojir 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferon‐α (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes

Early changes in interferon signaling de

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

✍ Birgit Edlich; Golo Ahlenstiel; Aintzane Zabaleta Azpiroz; Jonathan Stoltzfus; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Natural killer (NK) cells exhibit a polarized phenotype with increased cytotoxicity and decreased interferon gamma (IFN-c) production in chronic hepatitis C virus (HCV) infection. Here, we asked whether this is caused by type I interferon (IFN)-induced expression and phosphorylation levels of signal

Factors predictive of response to interf

Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection

✍ Byung-Il Yeh; Kwang-Hyub Han; Hyean-Woo Lee; Joon Hyung Sohn; Wang-Shick Ryu; Do 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## Abstract Interferon‐α (IFN‐α) has been used to treat hepatitis C Virus (HCV)‐induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN‐α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the begi

Virological patterns of hepatitis C viru

Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapy

✍ M S De Mitri; T Iervese; E Pisi; G Morsica; A Lazzarin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe

Systemic and intrahepatic interferon-gam

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

✍ Galia Askarieh; Åsa Alsiö; Paolo Pugnale; Francesco Negro; Carlo Ferrari; Avidan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB 👁 1 views

High systemic levels of interferon-gamma-inducible protein 10 kDa (IP-10) at onset of combination therapy for chronic hepatitis C virus (HCV) infection predict poor outcome, but details regarding the impact of IP-10 on the reduction of HCV RNA during therapy remain unclear. In the present study, we

Intrahepatic hepatitis C virus–specific

Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C

✍ David R. Nelson; Constantine G. Marousis; Tomoyoshi Ohno; Gary L. Davis; Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) have been shown to play a role in host defense and pathogenesis of chronic HCV infection. Our aim was to test the hypothesis that intrahepatic HCV-specific CTL activity may impact subsequent response to interferon alfa (IFN-␣) therapy. O